Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.

ABSTRACT:

SUBMITTER: Dargaud Y 

PROVIDER: S-EPMC5865419 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature